202 - Telehealth-based HCV Treatment Improves Access to Care for Individuals Who Utilize Syringe Service Programs

Presenting Author(s)

• 

  Sarah E. Rowan, MD

  Associate Director of HIV and Viral Hepatitis Prevention
  Denver Public Health
  Denver, CO, United States

  Slides

Co-Author(s)

• KK

  Kevin Kamis, Researcher

  Denver Health and Hospital Authority
  Denver, Colorado, United States
• EG

  Elizabeth Golding, n/a

  University of Colorado School of Medicine
  Aurora, Colorado, United States
• 

  Theodore Yoder (he/him/his)

  Medical Student
  University of Colorado School of Medicine
  Denver, CO, United States
• SG

  Sophia Goldin, n/a

  University of Colorado School of Medicine
  Denver, Colorado, United States
• MH

  Meron Haile, n/a

  Denver Health and Hospital Authority
  Denver, Colorado, United States
• LW

  Laura Weinberg, MPH

  Denver Health and Hospital Authority
  Denver, Colorado, United States
• RG

  Rachel Green, PharmD

  Denver Health and Hospital Authority
  Denver, Colorado, United States
• RK

  Ruth Kanatser, n/a

  Harm Reduction Action Center
  Denver, Colorado, United States
• JH

  Jason Haukoos, MD

  Denver Health and Hospital Authority
  Denver, Colorado, United States
• 

  David L. Wyles, MD

  Chief Division of Infectious Diseases
  Denver Health
  Denver, CO, United States